The People’s Vaccine Alliance has berated the proposed terms for waiving intellectual property rights on COVID-19 vaccine production, calling it a half measure that will not proffer an overarching solution to vaccine inequity.
Max Lawson, co-chair of the group in a mailed response to BusinessDa
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
